| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,926,042 | 13,219,979 | 12,130,775 | | Cost of Revenue | 2,563,159 | 2,822,439 | 2,245,139 | | | Gross Profit | 6,362,882 | 10,397,540 | 9,885,636 | | | Operating Expenses | | Research Development | 181,371 | 240,518 | 233,157 | | Selling General and Administrative | 2,648,438 | 6,049,970 | 4,992,633 | | Non Recurring |
-
|
-
|
-
| | Others | 2,130,211 | 1,955,249 | 1,635,442 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,402,862 | 2,151,802 | 3,024,405 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (152,040) | 345,612 | 229,381 | | Earnings Before Interest And Taxes | 1,250,822 | 2,444,071 | 2,480,988 | | Interest Expense | 292,818 | 260,250 | 257,253 | | Income Before Tax | 958,005 | 2,183,821 | 2,223,736 | | Income Tax Expense | 105,995 | 754,777 | 756,023 | | Minority Interest | 96,903 | 95,272 | 2,133 | | | | Net Income From Continuing Ops | 858,293 | 1,656,758 | 2,068,582 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 858,293 | 1,656,758 | 2,068,582 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $858,293 | $1,656,758 | $2,068,582 |
|
1.27% Nasdaq 
Income Statement
